SOLESENCE, INC. — Director's Dealing 2016

Feb 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2016-02-23

Reporting Person: JANKOWSKI JESS (Director, President, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-23	Common Stock (right to purchase)	$0.42	A	69000	Acquired	2026-02-23	Common Stock (69000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	38801	Direct
Common Stock	1000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to buy)	$6.01	2016-09-27	Common Stock (15000)	15000	Direct
Common Stock (right to buy)	$4.48	2017-11-06	Common Stock (18000)	18000	Direct
Common Stock (right to buy)	$3.14	2018-05-12	Common Stock (23000)	23000	Direct
Common Stock (right to buy)	$1.02	2019-05-04	Common Stock (30000)	30000	Direct
Common Stock (right to buy)	$1.70	2020-05-03	Common Stock (27000)	27000	Direct
Common Stock (right to buy)	$1.26	2021-05-02	Common Stock (85000)	85000	Direct
Common Stock (right to buy)	$0.30	2022-08-07	Common Stock (98000)	98000	Direct
Common Stock (right to buy)	$0.415	2023-02-14	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$0.52	2024-02-13	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$0.44	2025-02-18	Common Stock (81000)	81000	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal installments.

F3: Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.